Ambit Biosciences Announces Fourth Quarter And Full-Year 2013 Operating Results
3/21/2014 6:16:32 AM
SAN DIEGO, March 20, 2014 /PRNewswire/ -- Ambit Biosciences (AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced fourth quarter and full-year operating results for 2013. The company will host a conference call today to discuss financial results for the fourth quarter and full-year 2013, and to provide an outlook on plans for 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by